| Videos | Channels | Search |
Checkpoint inhibitor and immuno-oncology... (01:22:07)While there is great interest in the scientific community to...
|
Beyond discovery_Invest in your research with... (01:02:31)It’s a tough time to be in research, but QIAGEN is committed to...
|
Optimizing mouse model selection with OmicSoft... (01:22:07)Join us for an insightful webinar where you'll discover how to...
|
Discover biomarkers, validate targets and... (01:29:29)Learn how to leverage solutions from QIAGEN Digital Insights to...
|
Checkpoint inhibitor and immuno-oncology... (01:07:32)While there is great interest in the scientific community to...
|
OmicSoft DiseaseLand Training (01:03:30)This OmicSoft DiseaseLand training is designed to empower...
|
OmicSoft Studio RNA-seq and expression data... (01:28:16)In this 90-minute training, attendees will learn how to use basic...
|
Leveraging high-quality public proteomics data... (57:30)Per feedback from recent trainings, we are hosting a training...
|
Discovery from sample-level public data (GEO,... (55:36)Within QIAGEN Ingenuity Pathway Analysis (IPA), public data sourced...
|
Probing OncoLand using OmicSoft Studio (01:19:53)There's more than one way to probe our OncoLand data. With the...
|
Checkpoint inhibitor and immuno-oncology... (46:18)While there is great interest in the scientific community to...
|
Discoveries from comparing user data with... (01:22:46)Discoveries from comparing user data with high-quality public...
|
Switch to